Tin tức & Cập nhật

Debunking the myths about DPP-4 inhibitors

01 May 2024

Navigating the evolving landscape of diabetes management requires precise knowledge. In this exploration into the world of DPP-4 inhibitors (DPP4is), we aim to debunk prevalent myths and provide nuanced insights.

Debunking the myths about DPP-4 inhibitors

01 May 2024

Anticoagulation of little benefit to patients with device-detected AF, multiple comorbidities

30 Apr 2024 bởi

Giving oral anticoagulants to patients with device-detected atrial fibrillation (AF) and multiple comorbidities does not necessarily help lower the rate of cardiovascular events, according to a subgroup analysis of the NOAH-AFNET 6 trial.

Anticoagulation of little benefit to patients with device-detected AF, multiple comorbidities

30 Apr 2024

Disrupted delta wave activity during sleep predicts CVD, death

30 Apr 2024

Disruption of the delta wave activity while sleeping may be used to pinpoint individuals who are at heightened risk for cardiovascular disease (CVD) and CVD mortality, according to a study.

Disrupted delta wave activity during sleep predicts CVD, death

30 Apr 2024

Diltiazem carries increased risk of serious bleeding in certain AF patients

30 Apr 2024

The use of diltiazem, especially at doses exceeding 120 mg/d, appears to contribute to a heightened risk of serious bleeding compared with metoprolol in patients with atrial fibrillation (AF) who are receiving oral anticoagulant therapy, according to a retrospective cohort study.

Diltiazem carries increased risk of serious bleeding in certain AF patients

30 Apr 2024

CSR cuts angina episodes in patients with no further antianginal options

30 Apr 2024 bởi

In the placebo-controlled ORBITA-COSMIC* trial, an implantable coronary sinus reducer (CSR) does not increase transmural myocardial perfusion, but it reduces the frequency of angina and improves quality of life (QoL) in patients with no further antianginal options.

CSR cuts angina episodes in patients with no further antianginal options

30 Apr 2024

Higher doses of NSAID carry increased CVD risk in ankylosing spondylitis patients

26 Apr 2024

Patients with ankylosing spondylitis who are exposed to higher doses of nonsteroidal anti-inflammatory drugs (NSAIDs) appear to have an elevated risk of cardiovascular disease (CVD), according to a study.

Higher doses of NSAID carry increased CVD risk in ankylosing spondylitis patients

26 Apr 2024

SingHypertension: Primary care intervention for BP control deemed cost-effective

26 Apr 2024 bởi

A multicomponent intervention to control elevated blood pressure (BP) levels at the primary care level, SingHypertension, represents good value for money for reducing hypertension-related morbidity and mortality in Singapore, according to a cost-effectiveness study.

SingHypertension: Primary care intervention for BP control deemed cost-effective

26 Apr 2024

TAVI not inferior to SAVR in low-risk patients with severe aortic stenosis

26 Apr 2024 bởi

Use of transcatheter aortic valve implantation (TAVI) does not increase the risks and contributes to a decrease in the rates of death or stroke at 1 year in patients with severe aortic stenosis when compared with surgical aortic-valve replacement (SAVR), suggests a study presented at ACC.24.

TAVI not inferior to SAVR in low-risk patients with severe aortic stenosis

26 Apr 2024

Original New Drug Application Approvals by US FDA (1-15 April 2024)

26 Apr 2024

New drug applications approved by US FDA as of 1-15 April 2024 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (1-15 April 2024)

26 Apr 2024

Intravascular ultrasound-guided stenting delivers improved outcomes for ACS patients

25 Apr 2024 bởi

Using intravascular ultrasound (IVUS) to guide stent placement in patients with acute coronary syndrome (ACS) appears to reduce the 1-year risk of target vessel failure as compared with using angiography alone, according to the results of the IVUS-ACS study.

Intravascular ultrasound-guided stenting delivers improved outcomes for ACS patients

25 Apr 2024

Tin tức & Cập nhật

Lọc theo Chuyên ngành:

Chuyên ngành:

Debunking the myths about DPP-4 inhibitors

Debunking the myths about DPP-4 inhibitors

Anticoagulation of little benefit to patients with device-detected AF, multiple comorbidities

Anticoagulation of little benefit to patients with device-detected AF, multiple comorbidities

Disrupted delta wave activity during sleep predicts CVD, death

Disrupted delta wave activity during sleep predicts CVD, death

Diltiazem carries increased risk of serious bleeding in certain AF patients

Diltiazem carries increased risk of serious bleeding in certain AF patients

CSR cuts angina episodes in patients with no further antianginal options

CSR cuts angina episodes in patients with no further antianginal options

Higher doses of NSAID carry increased CVD risk in ankylosing spondylitis patients

Higher doses of NSAID carry increased CVD risk in ankylosing spondylitis patients

SingHypertension: Primary care intervention for BP control deemed cost-effective

SingHypertension: Primary care intervention for BP control deemed cost-effective

TAVI not inferior to SAVR in low-risk patients with severe aortic stenosis

TAVI not inferior to SAVR in low-risk patients with severe aortic stenosis

Original New Drug Application Approvals by US FDA (1-15 April 2024)

Original New Drug Application Approvals by US FDA (1-15 April 2024)

Intravascular ultrasound-guided stenting delivers improved outcomes for ACS patients

Intravascular ultrasound-guided stenting delivers improved outcomes for ACS patients